CHAMPIONS ONCOLOGY, INC. (CSBR) Return on equity 2018–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-29.8%FY2026 · since FY2018: -49200.0% → -29.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -29.8% | -154.5 pp |
| FY2025 | 124.6% | — |
| FY2023 | -115.1% | -121.1 pp |
| FY2022 | 6.0% | +1.2 pp |
| FY2021 | 4.9% | +45.9 pp |
| FY2020 | -41.0% | -47.0 pp |
| FY2019 | 6.0% | +49206.0 pp |
| FY2018 | -49200.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice